Company Profiles

driven by the PitchBook Platform

Anergis

Description

Provider of disease-modifying allergy immunotherapy services. The company develops allergy vaccines which aims at offering patients a long-term cure from allergies and reduce the treatment time.

2001

Founded

PRIVATE

Status

11-50

Employees

Series B

Latest Deal Type

$31.1M

Latest Deal Amount

$53.8M

Total Amount Raised

Description

Provider of disease-modifying allergy immunotherapy services. The company develops allergy vaccines which aims at offering patients a long-term cure from allergies and reduce the treatment time.

Website:

www.anergis.ch

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

Biopôle III Route de la Corniche 9B 1066 ÉpalingesSwitzerland +41 (0)21 651 9220
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Anergis's full profile, request a free trial.

    Anergis Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Anergis Investors (8)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    BioMedPartnersVenture CapitalMinority000 0000000 0000
    BlueOcean VenturesVenture CapitalMinority000 0000000 0000
    DEFI GestionPE/BuyoutMinority000 0000000 0000
    Esperante VenturesVenture CapitalMinority000 0000000 0000
    Renaissance KMU Schweizerische AnlagestiftungPE/BuyoutMinority000 0000000 0000
    BioMedPartners Venture Capital
    BlueOcean Ventures Venture Capital
    DEFI Gestion PE/Buyout
    Esperante Ventures Venture Capital
    Renaissance KMU Schweizerische Anlagestiftung PE/Buyout

    Anergis Executive Team (7)

    NameTitleBoard
    Seat
    Contact
    Info
    Vincent Charlon Ph.DChief Executive Officer
    Zoltán CziglerChief Financial Officer
    Kim SimonsenChief Development Officer
    Christophe Reymond Ph.DChief Scientific Officer
    Gerard Farmer Ph.DDirector, Regulatory Affairs
    Vincent Charlon Ph.D Chief Executive Officer
    Zoltán Czigler Chief Financial Officer
    Kim Simonsen Chief Development Officer
    Christophe Reymond Ph.D Chief Scientific Officer
    Gerard Farmer Ph.D Director, Regulatory Affairs

    Anergis Board Members (5)

    NameRepresentingRoleSinceContact
    Info
    Dino Dina MDSelfBoard Member000 0000
    Francois Spertini MDAnergisFounder, Chairman of Scientific Advisory Board & Vice Chairman000 0000
    Klaus Schollmeier Ph.DSelfChairman000 0000
    Markus Hosang Ph.DBioMedPartnersGeneral Partner000 0000
    Sten Verland Ph.DSunstone CapitalPartner000 0000
    Dino Dina MD Board Member Self
    Francois Spertini MD Founder, Chairman of Scientific Advisory Board & Vice Chairman Anergis
    Klaus Schollmeier Ph.D Chairman Self
    Markus Hosang Ph.D General Partner BioMedPartners
    Sten Verland Ph.D Partner Sunstone Capital
    Request full access to PitchBook